Tang Capital Management’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,345,413
Closed -$1.11M 209
2025
Q1
$1.11M Buy
1,345,413
+342,031
+34% +$329K 0.06% 148
2024
Q4
$953K Buy
+1,003,382
New +$947K 0.06% 153
2023
Q2
Sell
-200,000
Closed -$292K 106
2023
Q1
$292K Buy
+200,000
New +$383K 0.04% 90

Tang Capital Management's KRON Position: Q2 2025 in Review

Tang Capital Management sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 1,345,413 shares — an estimated $1.11M sold.

Tang Capital Management first reported a position in KRON in Q1 2023 and held it in 3 quarters. The position peaked at $1.11M in Q1 2025. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • Tang Capital Management reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • Tang Capital Management sold 1,345,413 Kronos Bio shares in Q2 2025, an estimated $1.11M.
  • Tang Capital Management first reported a position in Kronos Bio in Q1 2023 and held it in 3 quarters.
  • Tang Capital Management's Kronos Bio position peaked at $1.11M in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Tang Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.